Advanced glycation end product accumulation in rho0 cells without a functional respiratory chain

Biological Chemistry

Volumn 390, Issue 9, 2009, Pages 915-919

  Nass, Norbert ^a   Kukat, Alexandra ^b,c   Seibel, Peter ^b   Brömme, Hans Jürgen ^a   Schinzel, Reinhard ^d   Silber, Rolf Edgar ^a   Simm, Andreas ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Vasopharm GmbH   (Germany)

Author keywords

Advanced glycation end products; Mitochondria; Reactive oxygen species

Indexed keywords

ADVANCED GLYCATION END PRODUCT; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOL DERIVATIVE;

ARTICLE; BIOACCUMULATION; CANCER CELL CULTURE; CELL FRACTIONATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOCHONDRION; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RESPIRATORY CHAIN; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; ELECTRON TRANSPORT; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MITOCHONDRIA; REACTIVE OXYGEN SPECIES; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE;

EID: 70349464738     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.083     Document Type: Article

References (36)

1. Chandel, N.S. and Schumacker, P.T. (1999). Cells depleted of mitochondrial DNA (rho0) yield insight into physiological mechanisms. FEBS Lett. 454, 173-176.
2. Chevallet, M., Lescuyer, P., Diemer, H., van Dorsselaer, A., Leize- Wagner, E., and Rabilloud, T. (2006). Alterations of the mitochondrial proteome caused by the absence of mitochondrial DNA: a proteomic view. Electrophoresis 27, 1574-1583.
3. Gempel, K.E., Wagner, E.M., and Schleicher E.D. (1994). Production and characterization of antibodies against carboxymethyllysine- modified proteins. In: Maillard Reactions in Chemistry, Food and Health. Proceedings of the Fifth International Symposium on the Maillard Reaction, Minneapolis, 1993, T.P. Labuza, G.A. Reineccius, V. Monnier, J. Obrien and J. Baynes, eds. (Cambridge, UK: The Royal Society of Chemistry), pp. 392-396.
4. Grillo, M.A. and Colombatto, S. (2008). Advanced glycation endproducts (AGEs): involvement in aging and in neurodegenerative diseases. Amino Acids 35, 29-36.
5. Harman, D. (1972). The biologic clock: the mitochondria? J. Am. Geriatr. Soc. 20, 145-147.
6. Hiona, A. and Leeuwenburgh, C. (2008). The role of mitochondrial DNA mutations in aging and sarcopenia: implications for the mitochondrial vicious cycle theory of aging. Exp. Gerontol. 43, 24-33.
7. Jayaraman, S. (2005). Flow cytometric determination of mitochondrial membrane potential changes during apoptosis of T lymphocytic and pancreatic beta cell lines: comparison of tetramethylrhodamineethylester (TMRE), chloromethyl-Xrosamine (H2-CMX-Ros) and MitoTracker Red 580 (MTR580). J. Immunol. Methods 306, 68-79.
8. Kawaguchi, Y., Ito, A., Appella, E. and Yao, T.P. (2006). Charge modification at multiple C-terminal lysine residues regulates p53 oligomerization and its nucleus-cytoplasm trafficking. J. Biol. Chem. 281, 1394-1400.
9. Kukat, A., Kukat, C., Brocher, J., Schafer, I., Krohne, G., Trounce, I.A., Villani, G. and Seibel, P. (2008). Generation of rho0 cells utilizing a mitochondrially targeted restriction endonuclease and comparative analyses. Nucleic Acids Res. 36, e44.
10. Li, S.Y., Du, M., Dolence, E.K., Fang, C.X., Mayer, G.E., Ceylan- Isik, A.F., LaCour, K.H., Yang, X., Wilbert, C.J., Sreejayan, N., et al. (2005). Aging induces cardiac diastolic dysfunction, oxidative stress, accumulation of advanced glycation endproducts and protein modification. Aging Cell 4, 57-64.
11. Maeta, K., Izawa, S., Okazaki, S., Kuge, S., and Inoue, Y. (2004). Activity of the Yap1 transcription factor in Saccharomyces cerevisiae is modulated by methylglyoxal, a metabolite derived from glycolysis. Mol. Cell. Biol. 24, 8753-8764.
12. Marusich, M.F., Robinson, B.H., Taanman, J.W., Kim, S.J., Schillace, R., Smith, J.L., and Capaldi, R.A. (1997). Expression of mtDNA and nDNA encoded respiratory chain proteins in chemically and genetically-derived Rho0 human fibroblasts: a comparison of subunit proteins in normal fibroblasts treated with ethidium bromide and fibroblasts from a patient with mtDNA depletion syndrome. Biochim. Biophys. Acta 1362, 145-159.
13. Moye-Rowley, W.S., Harshman, K.D., and Parker, C.S. (1988). YAP1 encodes a yeast homolog of mammalian transcription factor AP-1. Cold Spring Harb. Symp. Quant. Biol. 53, 711-717.
14. Moye-Rowley, W.S., Harshman, K.D., and Parker, C.S. (1989). Yeast YAP1 encodes a novel form of the jun family of transcriptional activator proteins. Genes Dev. 3, 283-292.
15. Muller, F.L., Lustgarten, M.S., Jang, Y., Richardson, A., and Van Remmen, H. (2007). Trends in oxidative aging theories. Free Radic. Biol. Med. 43, 477-503.
16. Nass, N., Bartling, B., Navarrete Santos, A., Scheubel, R.J., Borgermann, J., Silber, R.E., and Simm, A. (2007). Advanced glycation end products, diabetes and ageing. Z. Gerontol. Geriatr. 40, 349-356.
17. Oya, T., Hattori, N., Mizuno, Y., Miyata, S., Maeda, S., Osawa, T., and Uchida, K. (1999). Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. J. Biol. Chem. 274, 18492-18502.
18. Papa, S. and Skulachev, V.P. (1997). Reactive oxygen species, mitochondria, apoptosis and aging. Mol. Cell. Biochem. 174, 305-319.
19. Rabbani, N. and Thornalley, P.J. (2008). The dicarbonyl proteome: proteins susceptible to dicarbonyl glycation at functional sites in health, aging, and disease. Ann. N.Y. Acad. Sci. 1126, 124-127.
20. Robinson, J.P. (1998). Oxygen and nitrogen reactive metabolites and phagocytic cells. In: Phagocyte Functions: A Guide for Research and Clinical Evaluation, J.P. Robinson and G. Babcock, eds. (New York, USA: Wiley-Liss), pp. 217-252.
21. Ruhs, S., Nass, N., Somoza, V., Friess, U., Schinzel, R., Silber, R.E., and Simm, A. (2007). Maillard reaction products enriched food extract reduce the expression of myofibroblast phenotype markers. Mol. Nutr. Food Res. 51, 488-495.
22. Simm, A., Nass, N., Bartling, B., Hofmann, B., Silber, R.E., and Navarrete Santos, A. (2008). Potential biomarkers of ageing. Biol. Chem. 389, 257-265.
23. Soh, N. (2006). Recent advances in fluorescent probes for the detection of reactive oxygen species. Anal. Bioanal. Chem. 386, 532-543.
24. Takeuchi, M. and Yamagishi, S. (2004a). Alternative routes for the formation of glyceraldehyde-derived AGEs (TAGE) in vivo. Med. Hypotheses 63, 453-455.
25. Takeuchi, M. and Yamagishi, S. (2004b). TAGE (toxic AGEs) hypothesis in various chronic diseases. Med. Hypotheses 63, 449-452.
26. Takeuchi, M., Makita, Z., Bucala, R., Suzuki, T., Koike, T., and Kameda, Y. (2000). Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo. Mol. Med. 6, 114-125.
27. Thornalley, P.J. (2006). Advanced glycation end products in renal failure. J. Ren. Nutr. 16, 178-184.
28. Thornalley, P.J. (2008). Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems - role in ageing and disease. Drug Metabol. Drug Interact. 23, 125-150.
29. Turner, P.R. and Denny, W.A. (1996). The mutagenic properties of DNA minor-groove binding ligands. Mutat. Res. 355, 141-169.
30. Vergani, L., Floreani, M., Russell, A., Ceccon, M., Napoli, E., Cabrelle, A., Valente, L., Bragantini, F., Leger, B., and Dabbeni- Sala, F. (2004). Antioxidant defences and homeostasis of reactive oxygen species in different human mitochondrial DNA-depleted cell lines. Eur. J. Biochem. 271, 3646-3656.
31. von Kleist-Retzow, J.C., Hornig-Do, H.T., Schauen, M., Eckertz, S., Dinh, T.A., Stassen, F., Lottmann, N., Bust, M., Galunska, B., Wielckens, K., et al. (2007). Impaired mitochondrial Ca2q homeostasis in respiratory chain-deficient cells but efficient compensation of energetic disadvantage by enhanced anaerobic glycolysis due to low ATP steady state levels. Exp. Cell Res. 313, 3076-3089.
32. Wardman, P. (2007). Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects. Free Radic. Biol. Med. 43, 995-1022.
33. Weiner, L.M., Hu, H., and Swartz, H.M. (1991). EPR method for the measurement of cellular sulfhydryl groups. FEBS Lett. 290, 243-246.
34. Yao, D., Taguchi, T., Matsumura, T., Pestell, R., Edelstein, D., Giardino, I., Suske, G., Ahmed, N., Thornalley, P.J., Sarthy, V.P., et al. (2006). Methylglyoxal modification of mSin3A links glycolysis to angiopoietin-2 transcription. Cell 124, 275-286.
35. Yao, D., Taguchi, T., Matsumura, T., Pestell, R., Edelstein, D., Giardino, I., Suske, G., Ahmed, N., Thornalley, P.J., Sarthy, V.P., et al. (2007a). Methylglyoxal modification of mSin3A links glycolysis to angiopoietin-2 transcription. Cell 128, 625.
36. Yao, D., Taguchi, T., Matsumura, T., Pestell, R., Edelstein, D., Giardino, I., Suske, G., Rabbani, N., Thornalley, P.J., Sarthy, V.P., et al. (2007b). High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J. Biol. Chem. 282, 31038-31045.